A vaccine has been developed to help prevent the recurrence of prostate cancer -LRB- cells pictured -RRB-
It 's designed to teach the immune system to recognise compounds found in prostate cancer cells and is being given to men who have already been treated for the cancer
can then destroy cancer cells without harming non-cancer cells
Researchers at the U.S. National Cancer Institute are using the vaccine on 70 men who have been treated for the cancer
Researchers at the U.S. National Cancer Institute are using the vaccine on 70 men who have been treated for the cancer
